Secretory bursts of growth hormone secretion in the dog may be initiated by somatostatin withdrawal
- 1 February 1984
- journal article
- research article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 62 (2), 199-207
- https://doi.org/10.1139/y84-030
Abstract
In 28 6-h experiments on 10 conscious resting trained male dogs, plasma growth hormone (GH) was determined at 5-min intervals by radioimmunoassay. For all experiments, the basal GH concentration in plasma was 0.80 ± 0.06 ng mL−1. In each experiment, 1–3 secretory bursts of GH occurred, raising plasma GH 2.4 to 15.3 times basal concentrations (for all 43 bursts, 6.6 ± 0.4 times the basal value). Metabolic clearance rates (MCR) and apparent distribution volumes (V) were determined, using stepwise infusions of canine GH. The MCR (3.99 ± 0.30 mL kg−1 min−1) and V (57.9 ± 5.5 mL kg−1) were used to transform the GH concentration versus time data into GH secretion rates, using a single compartment approach. Basal GH secretion rates for all 28 experiments were 3.12 ± 0.24 ng kg−1 min−1. The secretory bursts yield peak GH secretion rates of 9.4 ± 0.8 times basal secretion and these steep-sloped bursts last 25.1 ± 1.2 min. Six-hour infusions of 0.15 μg kg−1 min−1 of somatostatin (SRIF) abolished all secretory bursts but did not lower basal secretion rates. In five of seven SRIF infusion experiments in which samples were taken after the infusion ceased a secretory burst was seen in the hour following cessation of infusion (in four cases within 10 min). These secretory bursts lasted 23.0 ± 2.9 min and were similar to those seen in control experiments. Infusions of SRIF at 0.05 μg kg−1 min−1 had no effect. These results imply that during basal GH secretion, a surfeit of SRIF impinges on the somatotrophs, as extra SRIF does not further lower basal secretion. However, during secretory bursts, very little SRIF must be present, as exogenous SRIF blocks these bursts. The bursts are similar in duration to overshoots provoked in perifused dispersed rat somatotrophs by removal of an SRIF signal. It seems likely that their cause in vivo is similar. (All values are means ± SEM.)This publication has 18 references indexed in Scilit:
- Plasma immunoreactive somatostatin levels in rat hypophysial portal blood: Effect of glucagon administrationLife Sciences, 1978
- Validation of a single-compartment approach to the calculation of secretion rates of ACTHCanadian Journal of Physiology and Pharmacology, 1978
- Antiserum to Somatostatin Reverses Starvation-Induced Inhibition of Growth Hormone but Not Insulin Secretion*Endocrinology, 1978
- Interaction of Somatostatin Inhibition and Dibutyryl Cyclic AMP or Potassium Stimulation of Growth Hormone Release from Perifused Rat PituitariesEndocrinology, 1977
- Influence of Synthetic Somatostatin upon Growth Hormone Release from Perifused Rat PituitariesEndocrinology, 1976
- Metabolic Clearance and Secretion Rates of Porcine Growth Hormone in Genetically Lean and Obese SwineEndocrinology, 1976
- Antiserum to Somatostatin Prevents Stress-Induced Inhibition of Growth Hormone Secretion in the RatScience, 1976
- Plasma Growth Hormone Concentration in the Rat Determined by Radioimmunoassay: Influence of Sex, Pregnancy, Lactation, Anesthesia, Hypophysectomy and Extrasellar Pituitary TransplantsEndocrinology, 1966
- Survival of Endogenous Human Growth Hormone in PlasmaJournal of Clinical Endocrinology & Metabolism, 1964
- Practical Procedure for Estimation of Corticosterone or HydrocortisoneClinical Chemistry, 1958